Related Experiment Videos
[Molecular-genetic aspects of drug therapy of malignant tumors]
Abstract:
State and prospects of the drug cancer therapy are examined in the light of achievements of modern molecular oncology. Special attention is paid to the molecular genetic analysis of the appearance of individual and multiple cellular drug resistance in connection with amplification of definite genes as well as oncogenes. The idea about the possible role of oncogene activation as a universal cell reaction in response to an injury of environmental factors is advanced. It concerns both oncogenesis and induction of cancer cell drug resistance.
Insights
Modern molecular oncology reveals that oncogene activation may universally drive cancer development and drug resistance. Understanding these genetic mechanisms is key for advancing cancer therapy.
Area of Science:
- Molecular Oncology
- Cancer Genetics
Context:
- Examining the current state and future directions of drug cancer therapy.
- Leveraging advancements in modern molecular oncology.
Purpose:
- To analyze the molecular genetic basis of cellular drug resistance.
- To explore the role of gene amplification and oncogene activation in resistance.
Summary:
- Investigates cellular drug resistance mechanisms, focusing on gene amplification and oncogene activation.
- Proposes oncogene activation as a common cellular response to environmental damage, relevant to both cancer initiation and drug resistance.
Impact:
- Provides insights into the genetic underpinnings of cancer drug resistance.
- Highlights potential therapeutic targets by understanding oncogene roles in resistance.